Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE)
Osteoporosis International · 2025
DOI: 10.1007/s00198-025-07824-3 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Osteoporosis International, 2025. Verfasst von Mariana Diz Lopes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Section, Department of Medicine, University of Verona, Pz Scuro 10, 37134, Verona, Italy. Hauptthemen laut MEDLINE: Osteoporosis, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
The aim of this study was to evaluate the agreement between DXA and REMS in a cohort of SLE patients. REMS and DXA showed a fair to moderate agreement on osteoporosis diagnosis, with a similar ability to identify fracture risk. REMS tended to show lower bone mineral density and was more influenced by patients' demographics. BACKGROUND: The aim of this study was to assess the diagnostic agreement between Radiofrequency Echographic Multi Spectrometry (REMS) and dual-energy X-ray absorptiometry (DXA) for bone mineral density (BMD) in patients with systemic lupus erythematosus (SLE), particularly those receiving glucocorticoids (GCs). METHODS: One hundred-six SLE patients (44 GC-treated) underwent BMD assessment at the lumbar spine (LS), femoral neck (FN), and total hip (TH) using both DXA and REMS. We compared BMD and T-scores between methods and analyzed diagnostic agreement using linear regression, Cohen's kappa and Bland-Altman analysis. Receiver operator characteristic (ROC) curves evaluated the ability of REMS and DXA to discriminate fracture status. RESULTS: BMD measurements at all sites were significantly lower with REMS when compared with DXA across all skeletal sites (p < 0.001). Agreement in osteoporosis classification was slight to moderate (κ ranging from 0.229 at LS in all patients to 0.549 at FN in GC-treated patients). REMS showed moderate correlation with DXA and demonstrated 45% sensitivity and 88.4% specificity for diagnosing osteoporosis. Both REMS and DXA identified significant BMD differences between patients with and without vertebral fractures across all sites. ROC analysis revealed similar discriminative ability for fracture risk between REMS and DXA. REMS BMD values were more strongly associated with age, sex, and body mass index. CONCLUSION: REMS and DXA showed a fair to moderate agreement in osteoporosis diagnosis and in fracture discrimination in SLE patients. While REMS appears a supportive tool in this setting, particularly in GC-treated individuals, further longitudinal studies are warranted to validate its predictive value and clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology Section, Department of Medicine, University of Verona, Pz Scuro 10, 37134, Verona, Italy.
- Rheumatology Department, Unidade Local de Saúde de São João, Porto, Portugal.
- Rheumatology Section, Department of Medicine, University of Verona, Pz Scuro 10, 37134, Verona, Italy. giovanni.adami@univr.it.
Zitieren
APA
Lopes, M. D., Orsolini, G., Galvagni, I., Rotta, D., Dartizio, C., Benini, C., Fassio, A., Gatti, D., Viapiana, O., Rossini, M., & Adami, G. (2025). Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE). Osteoporosis International. https://doi.org/10.1007/s00198-025-07824-3
Vancouver
Lopes MD, Orsolini G, Galvagni I, Rotta D, Dartizio C, Benini C, et al. Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE). Osteoporosis International. 2025. doi:10.1007/s00198-025-07824-3
BibTeX
@article{Lopes2025,
author = {Lopes, Mariana Diz and Orsolini, Giovanni and Galvagni, Isotta and Rotta, Denise and Dartizio, Carmela and Benini, Camilla and Fassio, Angelo and Gatti, Davide and Viapiana, Ombretta and Rossini, Maurizio and Adami, Giovanni},
title = {Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE)},
journal = {Osteoporosis International},
year = {2025},
doi = {10.1007/s00198-025-07824-3}
}
EUVIMED